-
EP1294364
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1294364
| EP1294364 - STABLE GABAPENTIN HAVING PH WITHIN A CONTROLLED RANGE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.07.2008 Database last updated on 26.06.2024 | Most recent event Tooltip | 18.07.2008 | Application deemed to be withdrawn | published on 20.08.2008 [2008/34] | Applicant(s) | For all designated states TEVA PHARMACEUTICAL INDUSTRIES, LTD. 5 Basel Street, P.O. Box 3190 49131 Petah Tiqva / IL | [N/P] |
| Former [2003/13] | For all designated states TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 Basel Street, P.O. Box 3190 49131 Petah Tiqva / IL | Inventor(s) | 01 /
SINGER, Claude 8/8 David Elazar Kfar Saba / IL | 02 /
PILARSKI, Gideon 12 Atarot Holon / IL | 03 /
PESACHOVICH, Michael 5/11 Zvulon Hammer Givat Shmuel / IL | 04 /
SCHWARTZ, Eduard 68 Carmel Rehovot 76305 / IL | [2003/46] |
| Former [2003/13] | 01 /
SINGER, Claude 8/8 David Elazar Kfar Saba / IL | ||
| 02 /
PILARSKI, Gideon 12 Atarot Holon / IL | |||
| 03 /
PESACHOVICH, Michael 5/11 Zvulon Hammer Givat Shmuel / IL | Representative(s) | Nachshen, Neil Jacob, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB | [N/P] |
| Former [2003/13] | Nachshen, Neil Jacob, et al D Young & Co 21 New Fetter Lane London EC4A 1DA / GB | Application number, filing date | 01944600.4 | 15.06.2001 | [2003/13] | WO2001US19427 | Priority number, date | US20000211966P | 16.06.2000 Original published format: US 211966 P | [2003/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0197782 | Date: | 27.12.2001 | Language: | EN | [2001/52] | Type: | A1 Application with search report | No.: | EP1294364 | Date: | 26.03.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2001 takes the place of the publication of the European patent application. | [2003/13] | Search report(s) | International search report - published on: | US | 27.12.2001 | (Supplementary) European search report - dispatched on: | EP | 06.05.2004 | Classification | IPC: | A61K31/195, C07D209/96, C07C227/40, C07C227/44 | [2004/25] | CPC: |
A61K31/195 (EP,KR,US);
A61K9/145 (EP,US);
A61K9/2013 (EP,US);
A61P23/00 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/20 (EP);
C07C227/40 (EP,US);
C07C227/44 (EP,US);
C07D209/96 (EP,US);
A61K9/2054 (EP,US);
A61K9/2059 (EP,US);
C07C2601/14 (EP,US)
(-)
| C-Set: |
C07C227/40, C07C229/28 (EP,US);
C07C227/44, C07C229/28 (US,EP) |
| Former IPC [2003/13] | A61K9/20, A61K9/28, A61K9/32, A61K9/36, A61K9/42 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/13] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | 14.01.2003 | Title | German: | STABILES GABAPENTIN MIT EINEM PH INNERHALB EINES KONTROLLIERTEN BEREICHS | [2003/13] | English: | STABLE GABAPENTIN HAVING PH WITHIN A CONTROLLED RANGE | [2003/13] | French: | GABAPENTINE STABLE PRESENTANT UNE GAMME DE PH CONTROLEE | [2003/13] | Entry into regional phase | 14.01.2003 | National basic fee paid | 14.01.2003 | Search fee paid | 14.01.2003 | Designation fee(s) paid | 14.01.2003 | Examination fee paid | Examination procedure | 14.01.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 13.01.2003 | Amendment by applicant (claims and/or description) | 14.01.2003 | Examination requested [2003/13] | 05.10.2007 | Despatch of a communication from the examining division (Time limit: M04) | 16.02.2008 | Application deemed to be withdrawn, date of legal effect [2008/34] | 28.03.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/34] | Divisional application(s) | EP04005360.5 / EP1430893 | Fees paid | Renewal fee | 26.06.2003 | Renewal fee patent year 03 | 01.06.2004 | Renewal fee patent year 04 | 13.06.2005 | Renewal fee patent year 05 | 12.06.2006 | Renewal fee patent year 06 | 14.06.2007 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DX]WO9828255 (TEVA PHARMA [IL], et al) [DX] 1-8 * example - * * see especially example 1: steps A, B and C1 *; | [A]WO9959572 (WARNER LAMBERT CO [US], et al) [A] 1-8 * examples 1-3 *; | [A]WO9959573 (WARNER LAMBERT CO [US], et al) [A] 1-8* example -; claim - *; | [A] - ZOUR E ET AL, "STABILITY STUDIES OF GABAPENTIN IN AQUEOUS SOLUTIONS", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, (199205), vol. 9, no. 5, ISSN 0724-8741, pages 595 - 600, XP008018345 [A] 1-8 * abstract * * figure 6 * DOI: http://dx.doi.org/10.1023/A:1015833622943 | International search | [X]WO0007568 (PROGRAPHARM LAB [FR], et al); | [X]US6054482 (AUGART HELMUT [DE], et al); | [YP]WO0113894 (PUREPAC PHARMACEUTICAL CO [US]) | Examination | US4024175 | - ANONYMOUS, "Gabapentin", PHARMACOPEIAL FORUM, (1999), vol. 25, no. 5, pages 8711 - 8717 |